LICENSE AGREEMENTLicense Agreement • October 24th, 2008 • Maxygen Inc • Services-commercial physical & biological research • California
This LICENSE AGREEMENT (the “Agreement”), effective as of March 28, 2002 (the “Effective Date”), is made by and between Maxygen, Inc., a Delaware corporation (“MUS”), and Codexis, Inc., a Delaware corporation (“Codexis”).
AMENDMENT NO. 1 TO LICENSE AGREEMENTMaxygen Inc • October 24th, 2008 • Services-commercial physical & biological research
This Amendment No. 1 (“Amendment No. 1”) amends that certain License Agreement effective March 28, 2002 (the “Agreement”) entered by and between Maxygen, Inc. (“MUS”) and Codexis, Inc. (“Codexis”), and shall be effective as of September 13, 2002 (the “Amendment Date”). MUS and Codexis hereby amend the License Agreement as follows:
AMENDMENT NO. 3 TO LICENSE AGREEMENTLicense Agreement • October 24th, 2008 • Maxygen Inc • Services-commercial physical & biological research
This Amendment No. 3 (“Amendment No. 3”) amends that certain License Agreement effective March 28, 2002 entered by and between Maxygen, Inc. (“MUS”) and Codexis, Inc. (“Codexis”), as previously amended by Amendment No. 1 to License Agreement effective September 13, 2002, and Amendment No. 2 to License Agreement effective October 1, 2002, (as amended, the “Agreement”), and shall be effective as of August 22, 2006 (the “Third Amendment Date”). MUS and Codexis hereby amend the Agreement as follows:
